197 related articles for article (PubMed ID: 27404282)
21. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
22. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
[TBL] [Abstract][Full Text] [Related]
23. Aldo-keto reductase- and cytochrome P450-dependent formation of benzo[a]pyrene-derived DNA adducts in human bronchoalveolar cells.
Ruan Q; Gelhaus SL; Penning TM; Harvey RG; Blair IA
Chem Res Toxicol; 2007 Mar; 20(3):424-31. PubMed ID: 17295519
[TBL] [Abstract][Full Text] [Related]
24. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
25. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
26. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes.
Stiborova M; Cechova T; Borek-Dohalska L; Moserova M; Frei E; Schmeiser HH; Paca J; Arlt VM
Neuro Endocrinol Lett; 2012; 33 Suppl 3():8-15. PubMed ID: 23353838
[TBL] [Abstract][Full Text] [Related]
27. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
28. The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice.
Krais AM; Speksnijder EN; Melis JP; Indra R; Moserova M; Godschalk RW; van Schooten FJ; Seidel A; Kopka K; Schmeiser HH; Stiborova M; Phillips DH; Luijten M; Arlt VM
Arch Toxicol; 2016 Apr; 90(4):839-51. PubMed ID: 25995008
[TBL] [Abstract][Full Text] [Related]
29. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 system expression and DNA adduct formation in the liver of Zacco platypus following waterborne benzo(a)pyrene exposure: implications for biomarker determination.
Lee JW; Kim YH; Yoon S; Lee SK
Environ Toxicol; 2014 Sep; 29(9):1032-42. PubMed ID: 23192953
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
[TBL] [Abstract][Full Text] [Related]
33. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of and DNA adduct formation by benzo[alpha]pyrene in human skin epithelial cells in vitro pretreated with cytochrome P450 modulators.
Lehman TA; Kurian P; Milo GE
Cancer Biochem Biophys; 1989 Oct; 10(4):345-52. PubMed ID: 2515917
[TBL] [Abstract][Full Text] [Related]
35. Influence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene.
Hamouchene H; Arlt VM; Giddings I; Phillips DH
BMC Genomics; 2011 Jun; 12():333. PubMed ID: 21714911
[TBL] [Abstract][Full Text] [Related]
36. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
[TBL] [Abstract][Full Text] [Related]
37. Molecular Characterization and Functional Analysis of Cytochrome b5 Reductase (CBR) Encoding Genes from the Carotenogenic Yeast Xanthophyllomyces dendrorhous.
Gutiérrez MS; Rojas MC; Sepúlveda D; Baeza M; Cifuentes V; Alcaíno J
PLoS One; 2015; 10(10):e0140424. PubMed ID: 26466337
[TBL] [Abstract][Full Text] [Related]
38. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
[TBL] [Abstract][Full Text] [Related]
39. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
[TBL] [Abstract][Full Text] [Related]
40. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
